Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C15H15N3O.C3H6O3.H2O |
| Molecular Weight | 361.3923 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
O.CC(O)C(O)=O.CCOC1=CC2=C(N)C3=CC=C(N)C=C3N=C2C=C1
InChI
InChIKey=NYEPHMYJRNWPLA-UHFFFAOYSA-N
InChI=1S/C15H15N3O.C3H6O3.H2O/c1-2-19-10-4-6-13-12(8-10)15(17)11-5-3-9(16)7-14(11)18-13;1-2(4)3(5)6;/h3-8H,2,16H2,1H3,(H2,17,18);2,4H,1H3,(H,5,6);1H2
| Molecular Formula | C15H15N3O |
| Molecular Weight | 253.2991 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | H2O |
| Molecular Weight | 18.0153 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C3H6O3 |
| Molecular Weight | 90.0779 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
DescriptionCurator's Comment: description was created based on several sources, including, www.ncbi.nlm.nih.gov/pubmed/17294498, http://www.chemaxpharma.com/en/rivanol-chemax-pharma-0-1
Curator's Comment: description was created based on several sources, including, www.ncbi.nlm.nih.gov/pubmed/17294498, http://www.chemaxpharma.com/en/rivanol-chemax-pharma-0-1
Ethacridine (Rivanol) is an acridine derivative indicated for the treatment of bacterial infections. In many countries the drug was in clinical practice for the second trimester termination of pregnancy.
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Hemodialysis vascular access options in pediatrics: considerations for patients and practitioners. | 2009-06 |
|
| Effects of the selective serotonin reuptake inhibitor fluoxetine on counterregulatory responses to hypoglycemia in individuals with type 1 diabetes. | 2008-12 |
|
| Role of central nervous system glucagon-like Peptide-1 receptors in enteric glucose sensing. | 2008-10 |
|
| The design, development, and evaluation of a prototypic, prosthetic venous valve. | 2008-09-19 |
|
| Genomics, molecular imaging, bioinformatics, and bio-nano-info integration are synergistic components of translational medicine and personalized healthcare research. | 2008-09-16 |
|
| Effects of a selective serotonin reuptake inhibitor, fluoxetine, on counterregulatory responses to hypoglycemia in healthy individuals. | 2008-09 |
|
| Molecular epidemiology of A/H3N2 and A/H1N1 influenza virus during a single epidemic season in the United States. | 2008-08-22 |
|
| Mixtures of quaternary ammonium compounds and anionic organic compounds in the aquatic environment: Elimination and biodegradability in the closed bottle test monitored by LC-MS/MS. | 2008-06 |
|
| Sticky gecko feet: the role of temperature and humidity. | 2008-05-14 |
|
| Misoprostol preferable to ethacridine lactate for abortions at 13-20 weeks of pregnancy: Cuban experience. | 2008-05 |
|
| Second trimester abortions in India. | 2008-05 |
|
| Brisk walking compared with an individualised medical fitness programme for patients with type 2 diabetes: a randomised controlled trial. | 2008-05 |
|
| Strain-specific virulence phenotypes of Streptococcus pneumoniae assessed using the Chinchilla laniger model of otitis media. | 2008-04-09 |
|
| The Cuyahoga is still burning. | 2008-04 |
|
| Testosterone influences renal electrolyte excretion in SHR/y and WKY males. | 2008-03-26 |
|
| A 12 week, open label, phase I/IIa study using apatone for the treatment of prostate cancer patients who have failed standard therapy. | 2008-03-24 |
|
| A laparoscopic simulator tool for objective measurement of residents' laparoscopic ability. | 2008-02-02 |
|
| Antibiotics and antiseptics for venous leg ulcers. | 2008-01-23 |
|
| Norepinephrine to increase blood pressure in endotoxaemic pigs is associated with improved hepatic mitochondrial respiration. | 2008 |
|
| Anticancer Activity of Ag(I) N-Heterocyclic Carbene Complexes Derived from 4,5-Dichloro-1H-Imidazole. | 2008 |
|
| The Akron dome midfoot osteotomy as a salvage procedure for the treatment of rigid pes cavus: a retrospective review. | 2007-12-25 |
|
| Is mechanism of injury alone in the prehospital setting a predictor of major trauma - a review of the literature. | 2007-11-26 |
|
| Nodal signaling is required for closure of the anterior neural tube in zebrafish. | 2007-11-08 |
|
| Modeling and detection of respiratory-related outbreak signatures. | 2007-10-05 |
|
| Double blind, randomized, placebo controlled clinical trial for the treatment of diabetic foot ulcers, using a nitric oxide releasing patch: PATHON. | 2007-09-26 |
|
| The organizational effects of oxytocin on the central expression of estrogen receptor alpha and oxytocin in adulthood. | 2007-09-07 |
|
| Effects of interpregnancy interval and outcome of the preceding pregnancy on pregnancy outcomes in Matlab, Bangladesh. | 2007-09 |
|
| Phylogenetic review of tonal sound production in whales in relation to sociality. | 2007-08-10 |
|
| Left-sided gallbladder (sinistroposition) with duplication of the common bile duct. | 2007-07-27 |
|
| Physiologically-based testing system for the mechanical characterization of prosthetic vein valves. | 2007-07-13 |
|
| L5-S1 laparoscopic anterior interbody fusion. | 2007-06-20 |
|
| Baseline characteristics influencing quality of life in women undergoing gynecologic oncology surgery. | 2007-05-17 |
|
| A cell culture model using rat coronary artery adventitial fibroblasts to measure collagen production. | 2007-05-08 |
|
| An HPLC method for the determination of ethacridine lactate in human urine. | 2007-05 |
|
| Genetic mapping of a new heart rate QTL on chromosome 8 of spontaneously hypertensive rats. | 2007-04-09 |
|
| Genomic and expression analysis of multiple Sry loci from a single Rattus norvegicus Y chromosome. | 2007-04-04 |
|
| Construct validity of the endoscopic sinus surgery simulator: II. Assessment of discriminant validity and expert benchmarking. | 2007-04 |
|
| Silent rupture of unscarred uterus: an unusual presentation at second trimester abortion. | 2007-04 |
|
| Stimulation of MAP kinase pathways after maternal IL-1beta exposure induces fetal lung fluid absorption in guinea pigs. | 2007-03-26 |
|
| Outcomes of decompression for lumbar spinal canal stenosis based upon preoperative radiographic severity. | 2007-03-08 |
|
| Sry delivery to the adrenal medulla increases blood pressure and adrenal medullary tyrosine hydroxylase of normotensive WKY rats. | 2007-02-26 |
|
| Sex differences in judging self-orientation: the morphological horizon and body pitch. | 2007-01-07 |
|
| [Value of estrogen for preventing postpartum hemorrhage and shortening birth process in induce abortion]. | 2007-01 |
|
| The relationship between protein sequences and their gene ontology functions. | 2006-12-12 |
|
| Myocardial performance in conscious streptozotocin diabetic rats. | 2006-12-04 |
|
| The association between indwelling urinary catheter use in the elderly and urinary tract infection in acute care. | 2006-10-12 |
|
| Effects of tamoxifen on vaginal blood flow and epithelial morphology in the rat. | 2006-09-13 |
|
| Substance abuse prevention infrastructure: a survey-based study of the organizational structure and function of the D.A.R.E. program. | 2006-09-06 |
|
| Protein and overtraining: potential applications for free-living athletes. | 2006-06-05 |
|
| Community coalitions and prevention: a panel discussion. | 2004-08 |
Sample Use Guides
Apply 0,1 % cutaneous solution to the affected area of skin.
Route of Administration:
Topical
In Vitro Use Guide
Sources: DOI: 10.1159/isbn.978-3-318-00780-0, DOI: 10.1159/isbn.978-3-318-00780-0, Retrived from https://books.google.es/books?id=JkQOSAnOIhoC&pg=PA99&lpg=PA99&dq=ETHACRIDINE+mic&source=bl&ots=ghsA6y1h9Q&sig=6zSd_yIDEu9rFqfcJOX9sWPt_SA&hl=ru&sa=X&ved=0ahUKEwjbvvvK5u7OAhVKnRQKHWRQAzMQ6AEIJTAB#v=onepage&q=ETHACRIDINE%20mic&f=false
Ethacridine shows weak becteriostatic activity against gram-positive bacteria with MIC 1-10 ug/ml.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:49:55 GMT 2025
by
admin
on
Mon Mar 31 17:49:55 GMT 2025
|
| Record UNII |
V5IL571C1T
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-ATC |
D08AA01
Created by
admin on Mon Mar 31 17:49:55 GMT 2025 , Edited by admin on Mon Mar 31 17:49:55 GMT 2025
|
||
|
WHO-VATC |
QD08AA01
Created by
admin on Mon Mar 31 17:49:55 GMT 2025 , Edited by admin on Mon Mar 31 17:49:55 GMT 2025
|
||
|
WHO-VATC |
QB05CA08
Created by
admin on Mon Mar 31 17:49:55 GMT 2025 , Edited by admin on Mon Mar 31 17:49:55 GMT 2025
|
||
|
WHO-ATC |
B05CA08
Created by
admin on Mon Mar 31 17:49:55 GMT 2025 , Edited by admin on Mon Mar 31 17:49:55 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
V5IL571C1T
Created by
admin on Mon Mar 31 17:49:55 GMT 2025 , Edited by admin on Mon Mar 31 17:49:55 GMT 2025
|
PRIMARY | |||
|
CHEMBL94007
Created by
admin on Mon Mar 31 17:49:55 GMT 2025 , Edited by admin on Mon Mar 31 17:49:55 GMT 2025
|
PRIMARY | |||
|
DTXSID0046274
Created by
admin on Mon Mar 31 17:49:55 GMT 2025 , Edited by admin on Mon Mar 31 17:49:55 GMT 2025
|
PRIMARY | |||
|
SUB11944MIG
Created by
admin on Mon Mar 31 17:49:55 GMT 2025 , Edited by admin on Mon Mar 31 17:49:55 GMT 2025
|
PRIMARY | |||
|
165457
Created by
admin on Mon Mar 31 17:49:55 GMT 2025 , Edited by admin on Mon Mar 31 17:49:55 GMT 2025
|
PRIMARY | |||
|
6402-23-9
Created by
admin on Mon Mar 31 17:49:55 GMT 2025 , Edited by admin on Mon Mar 31 17:49:55 GMT 2025
|
PRIMARY | |||
|
m5041
Created by
admin on Mon Mar 31 17:49:55 GMT 2025 , Edited by admin on Mon Mar 31 17:49:55 GMT 2025
|
PRIMARY | Merck Index | ||
|
V5IL571C1T
Created by
admin on Mon Mar 31 17:49:55 GMT 2025 , Edited by admin on Mon Mar 31 17:49:55 GMT 2025
|
PRIMARY | |||
|
4107
Created by
admin on Mon Mar 31 17:49:55 GMT 2025 , Edited by admin on Mon Mar 31 17:49:55 GMT 2025
|
PRIMARY | RxNorm | ||
|
Ethacridine lactate
Created by
admin on Mon Mar 31 17:49:55 GMT 2025 , Edited by admin on Mon Mar 31 17:49:55 GMT 2025
|
PRIMARY | |||
|
100000076120
Created by
admin on Mon Mar 31 17:49:55 GMT 2025 , Edited by admin on Mon Mar 31 17:49:55 GMT 2025
|
PRIMARY | |||
|
SUB01985MIG
Created by
admin on Mon Mar 31 17:49:55 GMT 2025 , Edited by admin on Mon Mar 31 17:49:55 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ANHYDROUS->SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |